In addition, EVs from hypoxia-conditioned AD-MSCs increased the expression of CCL-2 at day 2, which plays an important role in macrophage recruitment leading to the upregulation of myogenic markers such as Pax7 and MyoD and new multinucleated muscle fibers [55]. The gene discussed is CCL2; the disease is Alzheimer disease.